Speaker Details

Benjamin Kaffenberger, MD, MS, FAAD

Benjamin Kaffenberger, MD, MS, FAAD

SESSIONS

S034 Late-Breaking Research: Session 2
Mar 28, 2026 • 12:00 AM - 12:00 AM • Bellco Theatre
F043 New Drugs, New Rashes: An Update on Cutaneous Drug Eruptions
Mar 28, 2026 • 12:00 AM - 12:00 AM • Room 301
F092 The Morbilliform Eruption: Differentiation and Treatment of Viral, Low-Risk Drug, Severe Cutaneous Adverse Reactions, and GVHD
Mar 30, 2026 • 12:00 AM - 12:00 AM • Mile High 1A

HANDOUTS

Login to view handouts

DISCLOSURES

Almirall – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); HCW Biologics – Investigator(Grants/Research Funding); InflaRx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); Leo Pharma – Investigator(Grants/Research Funding); National Comprehensive Cancer Network – Speaker(Honoraria); Pfizer Inc. – Data Safety Monitoring Board(Fees); Protillion Biosciences – Consultant (1099 relationship)(Stock Options);